Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105821090A details a novel NAD(H)-dependent StDapdh mutant for D-alanine synthesis, offering enhanced stability and cost-effective biocatalytic manufacturing solutions.
Patent CN108546691B discloses a novel 7β-HSDH mutant utilizing cheap NADH for ursodeoxycholic acid production, offering significant cost reduction and scalable biocatalysis solutions.
Patent CN107099516A details high-efficiency enzymatic UDCA production. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1119332C details a novel asymmetric hydrogenation route for azepine intermediates, offering cost-effective and scalable production for kinase inhibitors like Balanol.
Patent CN106701698A reveals high-efficiency enzymatic synthesis for chiral alcohols. Offers cost reduction and high purity for pharmaceutical supply chains.
Patent CN108546691A details a novel 7β-HSDH mutant using NADH for cost-effective ursodeoxycholic acid production with high purity and yield.
Novel Aeromonas caviae B18 strain enables high-purity chiral intermediate production with reduced costs and simplified downstream processing for pharma.
Patent CN104789505B reveals enzymatic route for high purity statin intermediates. Offers cost reduction and supply reliability for pharmaceutical manufacturing.
Patent CN1269950C details a novel biotechnological process for preparing amides using Amycolatopsis and Rhodococcus strains, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1220695A details a microbial process for chiral aminoalcohols, offering a scalable alternative to chemical synthesis for carbocyclic nucleosides.
Patent CN108300744A reveals enzymatic synthesis for high purity D-heterocyclic amino acids. This technology reduces cost and improves supply chain reliability for global pharmaceutical buyers seeking scalable intermediates.
Advanced biocatalytic method for high-purity nicotinamide. Reduces costs and improves supply chain reliability for pharmaceutical and feed industries globally.
Patent CN1224697C reveals a novel microbial process for high-purity aminoalcohols, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN104894148A details a high-efficiency omega-transaminase mutant for chiral amine synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN107686852B reveals a novel omega-transaminase route for moxifloxacin intermediates, offering high ee values and streamlined manufacturing for reliable pharmaceutical intermediate suppliers.
Patent CN113322219A reveals high-efficiency biocatalytic route for curcumin glucosides offering enhanced solubility and scalable production for pharmaceutical and food industries
Patent CN1266904A details a lipase-catalyzed process for high-purity stereoisomer carboxylates, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN102517353A details a green enzymatic route for heterocyclic ketones. Offers high ee values and mild conditions for pharma intermediates.
Patent CN119709674A reveals efficient BBE mutant for (S)-Scolerine. Enables cost reduction and scalable supply for pharmaceutical intermediate manufacturing.
Patent CN103497911B reveals ChKRED20 enzyme for high-efficiency synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.